BE737674A - - Google Patents

Info

Publication number
BE737674A
BE737674A BE737674DA BE737674A BE 737674 A BE737674 A BE 737674A BE 737674D A BE737674D A BE 737674DA BE 737674 A BE737674 A BE 737674A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE737674A publication Critical patent/BE737674A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BE737674D 1968-09-02 1969-08-19 BE737674A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR164817A FR7736M (enExample) 1968-09-02 1968-09-02

Publications (1)

Publication Number Publication Date
BE737674A true BE737674A (enExample) 1970-02-02

Family

ID=8654167

Family Applications (1)

Application Number Title Priority Date Filing Date
BE737674D BE737674A (enExample) 1968-09-02 1969-08-19

Country Status (5)

Country Link
BE (1) BE737674A (enExample)
DE (1) DE1944121A1 (enExample)
ES (1) ES371093A1 (enExample)
FR (1) FR7736M (enExample)
GB (1) GB1247306A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EP2332921B1 (en) * 2003-06-17 2016-03-02 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
CA2888392A1 (en) 2003-06-17 2005-03-03 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
EA201200954A1 (ru) 2004-12-21 2013-05-30 Арена Фармасьютикалз, Инк. Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение
RS50997B (sr) 2004-12-23 2010-10-31 Arena Pharmaceuticals Inc. Kompozicije 5ht2c receptor modulatora i postupci njihove upotrebe
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
JP5404414B2 (ja) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
CN103189053A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 用于体重控制的5-ht2c激动剂的调节释放剂型
JP2013539470A (ja) 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ, インコーポレイテッド ロルカセリンと光学活性な酸との塩
SG10201506865WA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
AU2011296015B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
UY34436A (es) 2012-10-09 2014-07-31 Arena Pharm Inc Metodo de control del peso

Also Published As

Publication number Publication date
DE1944121A1 (de) 1970-03-19
GB1247306A (en) 1971-09-22
ES371093A1 (es) 1971-08-16
FR7736M (enExample) 1970-03-09

Similar Documents

Publication Publication Date Title
AU5506869A (enExample)
AU5184069A (enExample)
FR7736M (enExample)
AU6168869A (enExample)
AU6171569A (enExample)
AU429879B2 (enExample)
AU4304568A (enExample)
AU4811568A (enExample)
AU4744468A (enExample)
BE725028A (enExample)
BE708951A (enExample)
BE726476A (enExample)
BE727785A (enExample)
BE723360A (enExample)
BE726540A (enExample)
BE713344A (enExample)
AU4464266A (enExample)
BE709496A (enExample)
BE709484A (enExample)
BE709479A (enExample)
BE709446A (enExample)
BE709435A (enExample)
BE709415A (enExample)
BE709320A (enExample)
BE709319A (enExample)